Table 7

Prognostic factors for disease-free survival on univariate analysis (log-rank test) in nonmetastatic patients

n = 75Patients%χ2P
Estrogen receptor negative versus estrogen receptor positive31418.130.004
Cytokeratin-positive cells in bone marrow37496.240.012
Clinical N1N2 versus N039525.790.016
Clinical T4 versus T3/T2/T116214.750.029
Tumor emboli33443.900.048
Cytokeratin-positive cells in peripheral blood12161.990.157
Tumor grade II/III versus I61811.440.230
Pre- versus postmenopausal43570.920.337
Progesterone receptor negative versus progesterone receptor positive45760.880.347
Histological pN > 3N+33440.850.354
Ductal versus other histology65870.010.957